No internet connection — showing the saved version of the page.

STRYKER CORP

USUSD
← to the screener
US:SYKLSE:0R2S

STRYKER CORP (US:SYK) — Medical/Dental Instruments. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
stryker.com
Investor relations
stryker.com/ir/en/index.html
Sector
Health Care · Medical/Dental Instruments
Headquarters
Portage, United States
Management
Kevin A. Lobo
  • Rachel Ruggeri · Director since 2024, Audit Committee Chair
  • Rajeev Suri · Director since 2018, Audit Committee
  • Andrew Silvernail · Director since 2013, Audit Committee
  • Lisa Skeete Tatum · Director since 2020, Audit Committee
Employees
22 000
Founded
1946
IPO
1980-03-17
Shares outstanding
380.69 M as of 2026-09-30
DateSharesChange
30.09.2026380.69 M−0.8%buyback
30.06.2026383.57 M
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Free float
348.14 M
Market cap
119.58 B USD
Insiders
5.36%
Institutions
82.84%
Industry (SIC)
Surgical & Medical Instruments & Apparatus
Legal form
U7HC
ISIN
US8636671013
LEI
5493002F0SC4JTBU5137
P/E
33.4
EPS
9.39 USD
|
5.08
ROE
15.8%
Payout ratio
36.8%
FCF
4.57 B USD
Payout / FCF
29%
Debt
14.9 B USD
2.5 y of FCF
Dividend streak
35 y
Earnings, FCF and dividends paid — for the 12 months to 30.09.2026 (the company's latest report).
Net income
3.62 B USD 12 mo.
For the 12 months to 30.09.2026 (4 quarters)
Revenue26.3 B USD
− Expenses21.0 B USD
Net income3.62 B USD
History by quarter
RevenueExpenses
31.12.2023: Revenue 5.82 B · Expenses 4.59 B · Operating profit 1.23 B · Net income 1.14 B31.03.2024: Revenue 5.24 B · Expenses 4.27 B · Operating profit 972 M · Net income 788 M30.06.2024: Revenue 5.42 B · Expenses 4.37 B · Operating profit 1.05 B · Net income 825 M30.09.2024: Revenue 5.49 B · Expenses 4.41 B · Operating profit 1.09 B · Net income 834 M31.12.2024: Revenue 6.44 B · Expenses 5.91 B · Operating profit 528 M · Net income 546 M31.03.2025: Revenue 5.87 B · Expenses 5.03 B · Operating profit 837 M · Net income 654 M30.06.2025: Revenue 6.02 B · Expenses 4.91 B · Operating profit 1.11 B · Net income 884 M30.09.2025: Revenue 6.06 B · Expenses 4.92 B · Operating profit 1.14 B · Net income 859 M31.12.2025: Revenue 7.17 B · Expenses 5.47 B · Operating profit 1.71 B · Net income 849 M31.03.2026: Revenue 6.02 B · Expenses 5.08 B · Operating profit 936 M · Net income 745 M30.06.2026: Revenue 6.59 B · Expenses 4.93 B · Operating profit 1.66 B · Net income 1.28 B30.09.2026: Revenue 6.52 B · Expenses 5.49 B · Operating profit 1.03 B · Net income 753 M
12.202309.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
61.62 USD · P/NAV 5.08
Balance sheet date30.09.2026
Assets47.2 B USD
− Liabilities23.8 B USD
= NAV (equity of the company's shareholders)23.5 B USD
− Goodwill19.3 B USD
− Intangible assets5.54 B USD
= Tangible NAV−1.41 B USD
Shares380 691 004
NAV per share61.62 USD
Tangible NAV per share−3.71 USD
Share price (SYK)313.27 USD
P/NAV5.08
NAV history
Balance sheet dateNAVNAV per share
30.09.202623.5 B USD61.62 USD
30.06.202624.0 B USD62.54 USD
31.03.202623.0 B USD59.94 USD
31.12.202522.4 B USD58.59 USD
30.09.202521.8 B USD56.97 USD
30.06.202521.2 B USD55.43 USD
31.03.202520.9 B USD54.77 USD
31.12.202420.6 B USD54.08 USD
Description

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
common stock
US USA StocksSYK primaryUSD313.27 -1.53%common stock
LSE London Stock Exchange0R2S IOBUSD313.89 +1.56%common stock
depositary receipt
SA B3 Sao PauloS1YK34BRL71.51 +0.00%depositary receipt
TO Toronto Stock ExchangeSYKCAD18.6 +0.87%depositary receipt

Price

Hover / tap a day — open, close, high and low prices

Dividends

Per year, US:SYK: 3.52 USD (4 paym.)

STRYKER CORP (SYK) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 3.52 USD per share (payments: 4). That is about 1.12% of the current share price. Based on payment history, the next ex-dividend date is expected around 30.12.2026. Uninterrupted dividend history: 35 years.

Ordinary shares

Ex-datePaymentAmount%TypeTicker
2026-09-302026-10-300.8800 USD0.3/1.3 %quarterlyUS:SYK
2026-06-302026-07-310.8800 USD0.3/1.1 %quarterlyUS:SYK
2026-03-312026-04-300.8800 USD0.3/1.1 %quarterlyUS:SYK
2025-12-312026-01-300.8800 USD0.2/1.0 %quarterlyUS:SYK
2025-09-302025-10-310.8400 USD0.2/0.9 %quarterlyUS:SYK
2025-06-302025-07-310.8400 USD0.2/0.8 %quarterlyUS:SYK
2025-03-312025-04-300.8400 USD0.2/0.9 %quarterlyUS:SYK
2024-12-312025-01-310.8400 USD0.2/0.9 %quarterlyUS:SYK
2024-09-302024-10-310.8000 USD0.3/1.0 %quarterlyUS:SYK
2024-06-282024-07-310.8000 USD0.3/1.0 %quarterlyUS:SYK
2024-03-272024-04-300.8000 USD0.3/1.0 %quarterlyUS:SYK
2023-12-282024-01-310.8000 USD0.3/1.0 %quarterlyUS:SYK
2023-09-282023-10-310.7500 USD0.2/1.0 %quarterlyUS:SYK
2023-06-292023-07-310.7500 USD0.2/0.9 %quarterlyUS:SYK
2023-03-302023-04-280.7500 USD0.2/0.9 %quarterlyUS:SYK
2022-12-292023-01-310.7500 USD0.2/0.9 %quarterlyUS:SYK
2022-09-292022-10-310.6950 USD0.2/0.9 %quarterlyUS:SYK
2022-06-292022-07-290.6950 USD0.2/0.7 %quarterlyUS:SYK
2022-03-302022-04-290.6950 USD0.2/0.4 %quarterlyUS:SYK
2021-12-302022-01-310.6950 USD0.2/0.2 %quarterlyUS:SYK

Depositary receipts

Ex-datePaymentAmount%TypeTicker
2026-09-29—0.157554 BRL0.2/0.9 %regularSA:S1YK34
2026-06-29—0.156208 BRL0.2/0.9 %regularSA:S1YK34
2026-03-30—0.152713 BRL0.2/0.9 %regularSA:S1YK34
2025-12-30—0.161949 BRL0.2/0.9 %regularSA:S1YK34
2025-09-29—0.157287 BRL0.2/0.9 %regularSA:S1YK34
2025-06-27—0.162964 BRL0.2/0.9 %regularSA:S1YK34
2025-03-28—0.165781 BRL0.2/0.9 %regularSA:S1YK34
2024-12-27—0.172522 BRL0.2/0.9 %regularSA:S1YK34
2024-09-27—0.162588 BRL0.2/1.0 %regularSA:S1YK34
2024-06-27—0.15869 BRL0.2/1.1 %regularSA:S1YK34
2024-03-27—0.143298 BRL0.2/1.1 %regularSA:S1YK34
2023-12-27—0.138662 BRL0.2/1.2 %regularSA:S1YK34
2023-09-28—0.131744 BRL0.2/1.2 %regularSA:S1YK34
2023-06-29—0.185801 BRL0.3/1.0 %regularSA:S1YK34
2023-03-30—0.18873 BRL0.3/1.0 %regularSA:S1YK34
2022-12-28—0.190181 BRL0.3/1.3 %regularSA:S1YK34
2022-09-29—0.178851 BRL0.3/≈1.0 %regularSA:S1YK34
2022-06-29—0.17931 BRL0.3/≈0.8 %regularSA:S1YK34
2022-03-30—0.174654 BRL0.2/≈0.5 %regularSA:S1YK34
2021-12-29—0.183494 BRL0.3/≈0.3 %regularSA:S1YK34
2026-10-01—0.059 CAD0.3/≈0.6 %regularTO:SYK
2026-06-30—0.06 CAD0.3/≈0.3 %regularTO:SYK

Top holders

HolderStakeSharesReport date
Blackrock Inc.7.15%27.41 M2026-06-30
Vanguard Capital Managem…5.88%22.54 M2026-06-30
JPMORGAN CHASE & CO4.5%17.26 M2026-06-30
State Street Corporation4.05%15.53 M2026-06-30
Greenleaf Trust3.97%15.23 M2026-06-30
Price (T.Rowe) Associate…3.11%11.92 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.86%10.95 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.33%8.94 M2026-06-30
Vanguard Portfolio Manag…2.13%8.17 M2026-06-30
Wellington Management Gr…2.13%8.17 M2026-06-30
Geode Capital Management…2.04%7.82 M2026-06-30
Morgan Stanley1.55%5.96 M2026-06-30
iShares Trust-iShares Co…1.21%4.66 M2026-07-31
Fidelity Concord Street…1.16%4.46 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.1%4.22 M2026-08-31
SELECT SECTOR SPDR TRT-S…0.65%2.48 M2026-08-31
VANGUARD SPECIALIZED FUN…0.63%2.43 M2026-04-30
VANGUARD INDEX FUNDS-Van…0.53%2.02 M2026-06-30
VANGUARD SPECIALIZED FUN…0.5%1.93 M2026-04-30
VANGUARD WELLINGTON FUND0.5%1.92 M2026-05-31
LOBO KEVIN A (Chief Exec…≈0.06%222 9522026-03-20
PIERCE JAMES ANDREW (Off…≈0.02%83 8892026-03-20
STILES SPENCER S (Presid…≈0.02%77 7202026-06-01
BECKER YIN C (Officer)≈0.01%36 0522025-03-21
SILVERNAIL ANDREW K. (Di…≈0%18 4652026-05-06
MENON VIJU S (Officer)≈0%17 5802026-03-20
GOLSTON ALLAN C (Directo…≈0%14 8952025-02-18
CROTTY DYLAN BRAM (Offic…——2026-08-21
FINK MARY KATHRYN (Offic…——2026-05-11
STRYKER RONDA E (Directo…——2026-08-19